RxDoctor Payments Data

Katherine Reuter

Nurse Practitioner · Lancaster, WINPI 1831466705

Payments from drug & device makers

$2,018in general payments, 2019–2025

Across 113 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$302
  • Pfizer$282
  • Biohaven Pharmaceutical Holding Company Ltd.$175
  • Lundbeck LLC$157
  • Boehringer Ingelheim$151
  • Novo Nordisk$138
  • plus $813 from 14 others

What the payments were for

  • Consulting fees$1005%
  • Food & beverage$1,91895%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,018 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$51,709
TrulicityDulaglutide44$41,749
FarxigaDapagliflozin Propanediol37$23,388
JardianceEmpagliflozin12$18,819
EliquisApixaban19$18,764
XareltoRivaroxaban14$18,672
MounjaroTirzepatide15$15,144
MyrbetriqMirabegron16$13,449
Breo ElliptaFluticasone/Vilanterol24$12,728
Semglee (Yfgn) PenInsulin Glargine-Yfgn23$10,834
Spiriva RespimatTiotropium Bromide12$5,869
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$5,865
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$4,562
Insulin Aspart FlexpenInsulin Aspart14$1,876
Albuterol Sulfate HfaAlbuterol Sulfate53$1,677

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$121$56,89359 claims
Novo NordiskOzempic$138$51,70939 claims
Boehringer IngelheimJardiance, Spiriva Respimat$151$24,68824 claims
AstraZenecaFarxiga$34$23,38837 claims
PfizerEliquis$282$18,76419 claims
Johnson & JohnsonXarelto$106$18,67214 claims
Astellas Pharma US IncMyrbetriq$82$13,44916 claims
GSKBreo Ellipta$15$12,72824 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

Other nurse practitioner in Lancaster

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →